These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17161714)

  • 1. A third episode of transfusion-derived vCJD.
    Wilson K; Ricketts MN
    Lancet; 2006 Dec; 368(9552):2037-9. PubMed ID: 17161714
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion transmission of vCJD: a crisis avoided?
    Wilson K; Ricketts MN
    Lancet; 2004 Aug 7-13; 364(9433):477-9. PubMed ID: 15302172
    [No Abstract]   [Full Text] [Related]  

  • 3. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.
    Peden AH; Head MW; Ritchie DL; Bell JE; Ironside JW
    Lancet; 2004 Aug 7-13; 364(9433):527-9. PubMed ID: 15302196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the US.
    Ponte ML
    PLoS Med; 2006 Oct; 3(10):e342. PubMed ID: 17076547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
    Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
    Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease.
    Oney D
    Pulse; 1999; 36(2):22. PubMed ID: 10614475
    [No Abstract]   [Full Text] [Related]  

  • 7. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products.
    Millar CM; Makris M
    Br J Haematol; 2012 Aug; 158(4):442-52. PubMed ID: 22775486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases.
    Puopolo M; Ladogana A; Vetrugno V; Pocchiari M
    Transfusion; 2011 Jul; 51(7):1556-66. PubMed ID: 21214582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Government confirms second case of vCJD transmitted by blood transfusion.
    Pincock S
    BMJ; 2004 Jul; 329(7460):251. PubMed ID: 15284140
    [No Abstract]   [Full Text] [Related]  

  • 10. Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion.
    Wkly Epidemiol Rec; 2000 Nov; 75(47):377-9. PubMed ID: 11144617
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfusion-related vCJD: prevention strategies for prion transmission.
    Holland PV
    Lijec Vjesn; 2007 May; 129 Suppl 3():46. PubMed ID: 18959066
    [No Abstract]   [Full Text] [Related]  

  • 12. Recipients of blood or blood products "at vCJD risk".
    Bird SM
    BMJ; 2004 Jan; 328(7432):118-9. PubMed ID: 14726314
    [No Abstract]   [Full Text] [Related]  

  • 13. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
    Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
    Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fall-out from a possible transfusion-related transmission of vCJD.
    Brown P
    Lancet Neurol; 2004 Apr; 3(4):203. PubMed ID: 15039029
    [No Abstract]   [Full Text] [Related]  

  • 15. vCJD and blood transfusion in the United Kingdom.
    Hewitt P
    Transfus Clin Biol; 2006 Nov; 13(5):312-6. PubMed ID: 17188541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients informed of increased risk of vCJD contact.
    Kmietowicz Z
    BMJ; 2004 Sep; 329(7468):702. PubMed ID: 15388598
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood transfusion and spread of variant Creutzfeldt-Jakob disease.
    Dietz K; Raddatz G; Wallis J; Müller N; Zerr I; Duerr HP; Lefèvre H; Seifried E; Löwer J
    Emerg Infect Dis; 2007 Jan; 13(1):89-96. PubMed ID: 17370520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries].
    Andersen O
    Lakartidningen; 2002 Mar; 99(12):1310-4. PubMed ID: 11998162
    [No Abstract]   [Full Text] [Related]  

  • 19. vCJD and blood transfusion.
    Wallis JP
    Br J Haematol; 2009 Jun; 145(5):669-70. PubMed ID: 19344391
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategies to reduce transfusion acquired vCJD.
    Wallis JP
    Transfus Med; 2011 Feb; 21(1):1-6. PubMed ID: 21070399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.